Loading…
Supriya Lifescience (SUPRIYA)₹631.25−3.03%Pharmaceuticals
Supriya Lifescience is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a P/E of 24.3 against a peer median of 39.9, and ROCE of 25.1% against a peer median of 12.1%, and latest-quarter sales growth of 50.7% against a peer median of 18.6%. By market cap it is #5 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| IOL Chemicals and Pharmaceuticals | 5,967 | 29.4 | 11.1 | 8.4 | 0.08 | 0.5 | 2,312 | 138 | 40.1 | 116.5 | vs SUPRIYA |
| Morepen Laboratories | 5,433 | 29.2 | 8.0 | 5.3 | 0.17 | 0.2 | 1,808 | 96 | 80.9 | 117.0 | vs SUPRIYA |
| Senores Pharmaceuticals | 5,417 | 40.6 | 15.0 | 13.5 | 0.37 | 0.0 | 632 | 122 | 18.6 | 23.4 | vs SUPRIYA |
| Orchid Pharma | 5,291 | 421.0 | 2.0 | 1.3 | 0.28 | 0.0 | 1,229 | 10 | 15.5 | — | vs SUPRIYA |
| Supriya Lifescience | 5,082 | 24.3 | 25.1 | 19.1 | 0.00 | 0.2 | 826 | 209 | 50.7 | 48.1 | — |
| SMS Pharmaceuticals | 4,809 | 46.8 | 13.0 | 14.2 | 0.46 | 0.1 | 886 | 102 | 5.6 | 4.9 | vs SUPRIYA |
| Gufic Biosciences | 4,760 | 64.8 | 12.0 | 10.2 | 0.61 | 0.0 | 948 | 64 | 16.6 | 69.1 | vs SUPRIYA |
| Aarti Drugs | 4,563 | 24.0 | 12.1 | 13.4 | 0.37 | 0.4 | 2,564 | 194 | 18.9 | −7.5 | vs SUPRIYA |
| Zota Health Care | 4,410 | — | −8.0 | −15.1 | 0.39 | 0.1 | 539 | −74 | 54.2 | — | vs SUPRIYA |
| Evonile Pharma | 4,343 | 44.5 | 16.0 | 11.7 | 0.00 | 0.0 | 353 | 93 | 18.1 | 14.3 | vs SUPRIYA |
| RPG Life Sciences | 4,283 | 39.1 | 26.0 | 19.3 | 0.03 | 0.9 | 708 | 115 | 16.4 | −24.3 | vs SUPRIYA |
| Peer median | 4,809 | 39.9 | 12.1 | 11.7 | 0.28 | 0.1 | 886 | 102 | 18.6 | 23.4 |
Listed companies closest to Supriya Lifescience in Pharmaceuticals include IOL Chemicals and Pharmaceuticals, Morepen Laboratories, Senores Pharmaceuticals, Orchid Pharma, SMS Pharmaceuticals, Gufic Biosciences, Aarti Drugs, Zota Health Care.
IOL Chemicals and Pharmaceuticals, with a market cap of ₹5,967 Cr.
Supriya Lifescience trades at a P/E of 24.3; the median of its peer set is 39.9. A P/E above or below the median is a description, not a judgement on value.
Supriya Lifescience's return on capital employed is 25.1%, above the peer median of 12.1%.